Top Ancillary Cannabis Plays Investors Are Watching in January 2026

Core Insights - The cannabis industry is evolving with increasing legalization in the U.S., and ancillary cannabis companies are emerging as attractive investment opportunities due to fewer regulatory hurdles compared to plant-touching operators [1] Group 1: GrowGeneration Corp. (GRWG) - GrowGeneration Corp. is a leading ancillary cannabis company specializing in hydroponic and organic gardening products for cannabis cultivators, operating over twenty retail and distribution locations across major markets like California, Colorado, and Florida [2] - The company has focused on restructuring and margin improvement, showing stabilizing revenue and improved gross margins due to a higher mix of proprietary brands, while also reducing operating expenses [3] - GrowGeneration reported positive adjusted EBITDA recently, marking a significant milestone, and maintains a strong cash position with minimal debt, providing flexibility during industry downturns [3] Group 2: Hydrofarm Holdings Group, Inc. (HYFM) - Hydrofarm Holdings Group manufactures and distributes hydroponic equipment for commercial growers, with a strong presence in West Coast cannabis markets and a broad product portfolio [6] - The company has faced challenges due to industry oversupply, leading to revenue declines and increased losses, but is focusing on restructuring initiatives to stabilize operations [8] - Despite weaker demand, Hydrofarm's brands retain loyalty among professional cultivators, and its diversification into indoor food production markets provides some revenue insulation [8] Group 3: The Scotts Miracle-Gro Company (SMG) - The Scotts Miracle-Gro Company, known for lawn and garden products, has a division called Hawthorne Gardening that supplies hydroponic growers with essential cultivation technology [9] - While Hawthorne's sales have declined due to slowed cultivation, Scotts remains profitable and cash-generative, supported by its core lawn and garden products [10] - The company generates strong free cash flow and has publicly supported cannabis reform initiatives, which could benefit Hawthorne if federal policies shift favorably [10]